6-[5-AMINO-6-(2-ETHOXYETHOXY)-IMIDAZO[4,5-B]PYRIDIN-3-YL]-NICOTI NONITRILE DERIVATIVES AND THEIR USE AS IRAK INHIBITORS
The present invention discloses compounds according to Formula (I): wherein R1, R2, and Cy are as defined herein. The present invention relates to compounds inhibiting IRAK family kinases, methods for their production, pharmaceutical compositions comprising the same, and methods of treatment using t...
Saved in:
Main Authors | , , , , , , , , , |
---|---|
Format | Patent |
Language | English Spanish |
Published |
27.06.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention discloses compounds according to Formula (I): wherein R1, R2, and Cy are as defined herein. The present invention relates to compounds inhibiting IRAK family kinases, methods for their production, pharmaceutical compositions comprising the same, and methods of treatment using the same, for the prophylaxis and/or treatment of inflammatory diseases, autoimmune diseases and/or proliferative diseases by administering the compound of the invention.
La presente invención describe compuestos de acuerdo con la Fórmula I: (ver Fórmula) en donde R1, R2, y Cy son como se definen en el presente documento. La presente invención se refiere a compuestos que inhiben las cinasas de la familia IRAK, métodos para su producción, composiciones farmacéuticas que comprenden los mismos, y métodos de tratamiento que utilizan los mismos, para la profilaxis y/o tratamiento de enfermedades inflamatorias, enfermedades autoinmunes y/o enfermedades proliferativas mediante la administración del compuesto de la invención. |
---|---|
Bibliography: | Application Number: MX20180004517 |